MARKET

XFOR

XFOR

X4 Pharmaceuticals Inc
NASDAQ
4.040
+0.010
+0.25%
After Hours: 4.040 0 0.00% 19:30 08/21 EDT
OPEN
4.050
PREV CLOSE
4.030
HIGH
4.175
LOW
4.005
VOLUME
1.22M
TURNOVER
--
52 WEEK HIGH
4.830
52 WEEK LOW
2.450
MARKET CAP
400.55M
P/E (TTM)
-3.2570
1D
5D
1M
3M
1Y
5Y
1D
X4 Pharmaceuticals: Making Progress, But The Market Is Ahead Of The Trial (Rating Downgrade)
Seeking Alpha · 3d ago
Weekly Report: what happened at XFOR last week (0810-0814)?
Weekly Report · 5d ago
Top Executives Make Major Moves With X4 Pharmaceuticals Shares
TipRanks · 08/14 02:06
Airsculpt Technologies, Barrick Mining And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
Benzinga · 08/10 12:02
Weekly Report: what happened at XFOR last week (0803-0807)?
Weekly Report · 08/10 09:58
Press Release: X4 Pharmaceuticals Reports Second -2-
Dow Jones · 08/06 20:15
X4 Pharmaceuticals: Q2 Earnings Snapshot
Barchart · 08/06 16:20
Weekly Report: what happened at XFOR last week (0727-0731)?
Weekly Report · 08/03 09:58
More
About XFOR
X4 Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on discovering and developing novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. Its lead clinical candidate is mavorixafor, a small-molecule selective antagonist of chemokine receptor CXCR4. It has developed a small-molecule, oral antagonists of the chemokine receptor C-X-C receptor type 4 (CXCR4). It has two pre-clinical candidates: X4P-003, a second-generation CXCR4 antagonist designed to have enhanced properties relative to mavorixafor, potentially enabling opportunities in CXCR4-dependent disorders and primary immunodeficiencies, and X4P-002, a CXCR4 antagonist with a distribution profile and a demonstrated ability to cross the blood-brain barrier.

Webull offers X4 Pharmaceuticals Inc stock information, including NASDAQ: XFOR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XFOR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XFOR stock methods without spending real money on the virtual paper trading platform.